United States Genomics in Cancer Care Market Set to Surge to USD 51.1B by 2031 at 18.9% CAGR | Roche Diagnostics, AstraZeneca PLC, Illumina, Inc.

Genomics In Cancer Care Market reached USD 13.4 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 51.1 billion by 2031. The Global Genomics in Cancer Care Market is expected to exhibit a CAGR of 18.9% during the forecast period 2024-2031.

The Genomics in Cancer Care market focuses on applying genomic technologies to detect, diagnose, and personalize cancer treatment. Genomic profiling helps identify mutations, biomarkers, and targeted therapies. Rising cancer prevalence globally drives strong demand for genomic solutions. Advancements in sequencing technologies and bioinformatics improve accuracy and affordability. Investments in precision oncology and growing clinical adoption further accelerate market growth.

📌 Request Sample Report to Access Investor Opportunity Matrix -"Genomics in Cancer Care Market" Deals & Growth Hotspots:- https://datamintelligence.com/download-sample/genomics-in-cancer-care-market?rk

☛ Genomics in Cancer Care Market Recent Developments 2025:

United States: Recent Industry Developments

✅ In August 2025, a U.S. biotech company launched a genomics-driven precision oncology platform.
It integrates sequencing data with AI treatment recommendations.
Major cancer centers are adopting it.

✅ In June 2025, FDA approved a multi-gene panel test for personalized cancer therapy.
It covers solid tumors and hematological cancers.
Commercial rollout is nationwide.

✅ In April 2025, a genomics firm secured funding for liquid biopsy genomic profiling.
The technology detects cancer mutations from blood samples.
Trials are being conducted in hospitals.

Japan: Recent Industry Developments

✅ In July 2025, a Japanese cancer institute launched a genomics-guided clinical trial network.
It links hospitals to speed up precision oncology.
Enrollment for breast and lung cancers is underway.

✅ In May 2025, Japan's regulators approved a companion diagnostic based on genomic profiling.
It is paired with a new targeted therapy.
Hospitals are integrating the test.

✅ In February 2025, a Tokyo startup rolled out AI-powered genomics interpretation software.
The tool reduces turnaround time for clinical reports.
Oncologists are adopting it in large hospitals.

☛ Genomics in Cancer Care Market Dynamics:

Genomics-driven cancer care expands as sequencing, liquid biopsy, and pan-cancer genomic panels enable more personalized diagnostics and targeted therapies. Clinical guidelines increasingly incorporate genomic biomarkers for therapy selection and prognosis.

Improved reimbursement frameworks, faster sequencing turnaround, and actionable variant interpretation tools boost clinical uptake. Integration with oncology care pathways and real-world evidence generation will broaden the role of genomics in routine cancer management.

☛ Genomics in Cancer Care Market Major Companines and ROI Analysis:

Roche Diagnostics, AstraZeneca PLC, Illumina, Inc., Affymetrix, Agilent Technologies, Cancer Genetics Inc., Beckman Coulter Inc., Bio-Rad Labs, Danaher Corporation, and Sigma Aldrich Corporation (Merck KGaA) among others.

Research Methodology

We employ a hybrid approach, integrating qualitative insights with robust quantitative analysis to deliver comprehensive and reliable market intelligence. The process starts with extensive secondary research, leveraging trusted industry publications, proprietary databases, and credible market sources. This foundation is then strengthened through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request Customized Market Entry Assessment for North America, EU, APAC: https://datamintelligence.com/customize/genomics-in-cancer-care-market

☛ Segment Covered in the Genomics in Cancer Care Market:

By Product; Instruments, Consumables, Services

By Application: Diagnostics, Personalized Medicine, Drug Discovery & Development, Research

By Technology: Genome Sequencing, PCR, Microarray, Nucleic Acid Extraction and Purification

By End User: Hospitals, Clinics, Ambulatory Surgical Centers

☛ This Report Covers:

✔ Comprehensive go-to-market strategy insights.

✔ An unbiased evaluation of market performance.

✔ In-depth analysis of development trends, competitive landscape, supply and demand dynamics, year-on-year growth, competitive benchmarking, vendor mapping, market access, and overall development status.

✔ Customized regional and country-level reports available on request, including detailed localized analysis.

✔ Identification of potential and niche segments/regions showcasing strong growth opportunities.

✔ Application of both top-down and bottom-up approaches for accurate regional market analysis.

📌 Get Corporate Access to Live Genomics in Cancer Care Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=genomics-in-cancer-care-market

☛ Regional Analysis for Genomics in Cancer Care Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

☛ Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the Genomics in Cancer Care Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global Genomics in Cancer Care Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the Genomics in Cancer Care Market?
➠ What sales, marketing, and distribution channels are used globally?

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.